BEIJING, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Monday, August 18, 2008 to discuss results for the quarter ended June 30, 2008.
To participate in this live conference call, please dial 888-339-2688 five to ten minutes prior to the scheduled conference call time. International callers should dial 617-847-3007. The conference Passcode is 899 273 89.
For those who are unable to participate in the conference call at the time of the call, a replay will be available for fourteen days starting on August 18, at 10:00 a.m. Eastern Time. To access the replay, please dial 888-286- 8010. International callers should dial 617-801-6888. The replay Passcode is 522 821 17.
About Yongye Biotechnology International, Inc.
Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development, distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.
Forward Looking Statements
Certain statements set forth in this press release constitute "Forward-
looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements include, without limitation,
any statement that may predict, forecast, indicate, or imply future
results, performance or achievements, and may contain the words "estimate,"
"project," "intend," "forecast," "anticipate," "plan," "planning,"
"expect," "believe," "will," "will likely," "should," "could," "would,"
"may" or words or expressions of similar meaning. All such forward-looking
statements involve risks and uncertainties, including, but not limited to:
statements regarding the Company's products; marketing and sales; patents
and regulatory approvals; the effect of competition and proprietary rights
of third parties; the need for and availability of additional financing and
access to capital; the seeking of joint development, licensing or
distribution and collaboration and marketing arrangements with other
companies. There can be no assurance that such forward-looking statements
will prove to be accurate and Yongye undertakes no obligation to update any
forward-looking statements or to announce revisions to any of the
For more information, please contact:
Yongye Biotechnology International, Inc.
Mr. Larry Gilmore-VP of Corporate Strategy
CCG Investor Relations, Inc.
Mr. Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Web site: http://www.ccgir.com
|SOURCE Yongye Biotechnology International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved